Search
for
Sort by
Research 961–990 of 1000+
- A review of Janus kinase inhibitor use in scarring alopecia
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies
- The Role of Entrepreneurial Leadership and Innovation in the Future of Therapeutic Dermatology
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
- Biotics for Acne-Prone Skin and Scalp Disorders: A Scoping Review
- 75993 Safety of Janus kinase inhibitors for treatment of alopecia areata
- Adipose Tissue‐Derived Exosomes in the Treatment of Lichen Planopilaris: A Case Report
- COMPARATIVE STUDY OF TWO CONCENTRATIONS (2.5MG/ML AND 5 MG/ML) OF INTRALESIONAL TRIAMCINOLONE ACETONIDE IN THE TREATMENT OF ALOPECIA AREATA
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- 272 Dupilumab treatment in children with alopecia areata: A real-world, single-center observational study
- A clinicoepidemiological study of geriatric dermatoses
- Successful treatment of rare linear lichen planopilaris with Ixekizumab
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia areata mit gutem Ansprechen auf Tofacitinib
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- Alopecia Areata
- New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Update on hidradenitis suppurativa: connecting the tracts
- Lipid Profile and Metabolic Syndrome Status in Patients with Oral Lichen Planus, Oral Lichenoid Reaction and Healthy Individuals Attending a Dental College in Northern India - A Descriptive Study
- Substance P in keratosis follicularis spinulosa decalvans
- Prognostic Factors in Mexican Patients with Patchy and Other Types of Alopecia Areata
- Epidemiology, clinical features, and outcome of the hospitalized patients with Kerion in Fars Province, Iran: an eleven-year retrospective study
- Targetoid Polycyclic Concentric Hair Regrowth Pattern Is a Sign of Immunological Recovery in Alopecia Areata
- Dermoscopy and Ultraviolet-Enhanced Fluorescence Dermoscopy (UEFD) Increase the Accuracy of Diagnosis and Are Useful in Assessing the Effectiveness of Kerion celsi Treatment
- A Systematic Review on Clinical Evidence for Topical Metformin: Old Medication With New Application
- Clinicopathologic Case 2: Multiple Intraoral White Lesions in a 55-year-old Female